Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Vesicle fusion regulation in metabolism

Award Number: R01DK142287
ORGANIZATION: NATIONAL INSTITUTE OF DIABETES & DIGESTIVE & KIDNEY DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 02/19/2026
PERIOD OF PERFORMANCE END DATE: 01/31/2029

Group Awards By:

View Award Description

Vesicle fusion regulation in metabolism - PROJECT SUMMARY Many metabolic responses involve the trafficking of proteins within the endomembrane system. A major branch of membrane protein trafficking is vesicle fusion, which entails the merging of membrane-enclosed vesicles with their target membranes. Vesicle fusion mediates key metabolic processes, including the translocation of the glucose transporter GLUT4, insulin secretion, glucagon release, and GLP-1 secretion. Imbalances in these vesicle fusion processes are associated with metabolic disorders such as insulin resistance (IR) and type 2 diabetes (T2D). To devise effective therapeutic strategies for these disorders, it is crucial to understand how protein-protein networks mediate and regulate vesicle fusion in these metabolic pathways. Our research focuses on the vesicle fusion pathway critical for the insulin-dependent translocation of GLUT4 in adipocytes and muscle cells. In our preliminary studies, we developed CRISPR-based genetic platforms and identified new players in the vesicle fusion pathway. Additionally, through biochemical and biophysical assays, we uncovered novel protein-protein and protein-membrane binding modes in GLUT4 vesicle fusion. In this work, we aim to expand these preliminary findings to elucidate how the soluble and membrane proteins act in concert to mediate and regulate the vesicle fusion reaction and to understand how fusion kinetics are affected by changes in lipid composition. Our genetic experiments employ cultured adipose and muscle cells differentiated from progenitor cells, as well as genetically modified mouse strains. We will also use a novel platform of mature human adipocytes derived from differentiation of human pluripotent stem cells. As a crucial step towards grasping the molecular basis of IR, we will use mouse models to explore how a high-fat diet-induced IR condition affects vesicle fusion mediators. The experiments proposed here are expected to provide key mechanistic insights into the molecular basis of metabolic vesicle fusion, and will pave the way for understanding IR and T2D. Ultimately, these findings will likely contribute to the development of new treatments for these metabolic disorders.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $551,250 )
2026	2026	THE REGENTS OF THE UNIVERSITY OF COLORADO	3100 MARINE ST	BOULDER	CO	80309	BOULDER	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	1	2/19/2026	NEW	$551,250
														Subtotal = $551,250

Grand Total All Awards = $551,250

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Vesicle fusion regulation in metabolism

Award Number: R01DK142287

ORGANIZATION: NATIONAL INSTITUTE OF DIABETES & DIGESTIVE & KIDNEY DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 02/19/2026

PERIOD OF PERFORMANCE END DATE: 01/31/2029

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer